Skip to main content
Caplight Logo









Axoft

Axoft

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://axoft.us/

Last Round

Series A

Apr 29, 2026

Est. Valuation

$33M

Total Funding Raised

$63M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Axoft is a neurotechnology company that develops implantable Brain-Computer Interfaces (iBCIs) using novel, ultra-soft materials to treat neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Biotechnology, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Data as a Service, Services & Consulting, Government Contracts

AI Layer

Foundation

Keywords

brain-computer interfacebrain implantsoft brain implantBCIneural implantneurological disordersiBCIneurotechnologyneurotechsoft biomaterialneural decodingbrain techmedical deviceBrain Foundation Modelbio-inspired implantslong-term neural recordingbiomarker discoveryepilepsy treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Axoft Comparables

Compare Axoft with similar companies based on industry and business-model similarity.

Axoft comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
INBRAIN Neuroelectronics
84%
NeuroXess
82%
Neurosoft Bioelectronics
82%

Axoft Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 29, 2026
SeedOct 18, 2022

Axoft Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 79% MoM, reaching 6.5K.

  • Apr 29, 2026

    Raised $55M led by C.P. Group Innovation.

Recent news

Latest coverage and updates

  • launchesAug 25, 2026

    Axoft, Inc. launched Fleuron WISE on Aug 25th '26.

Axoft Filings

Explore SEC and related filing metadata, where available.

Axoft filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Axoft's valuation, stock price, and market status.

Is Axoft a public or private company?

Axoft is a private company.

What is the current stock price of Axoft?

Axoft is a private company with no public stock price. No recent secondary market data is available.

How much is Axoft worth (valuation)?

Valuation information for Axoft is not publicly available.

Can I buy Axoft stock?

Axoft shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Axoft's last funding round?

Axoft's most recent funding round was Series A on April 29, 2026.

Who are the main investors in Axoft?

Key investors in Axoft include C.P. Group Innovation.

Will Axoft IPO soon?

No public IPO plans have been announced for Axoft.

How can I track Axoft secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Axoft's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range36
Year Founded2021
Last FundingApr 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?